
### [MONDO:0018531](http://purl.obolibrary.org/obo/MONDO_0018531)
**Label:** carcinoma of liver and intrahepatic biliary tract

**Subclasses:** [MONDO:0018427](http://purl.obolibrary.org/obo/MONDO_0018427) (fibrolamellar hepatocellular carcinoma), [MONDO:0018534](http://purl.obolibrary.org/obo/MONDO_0018534) (squamous cell carcinoma of liver and intrahepatic biliary tract), [MONDO:0016216](http://purl.obolibrary.org/obo/MONDO_0016216) (adult hepatocellular carcinoma), [MONDO:0018666](http://purl.obolibrary.org/obo/MONDO_0018666) (hepatoblastoma), [MONDO:0018535](http://purl.obolibrary.org/obo/MONDO_0018535) (biliary cystadenocarcinoma), [MONDO:0018532](http://purl.obolibrary.org/obo/MONDO_0018532) (adenocarcinoma of liver and intrahepatic biliary tract), [MONDO:0018533](http://purl.obolibrary.org/obo/MONDO_0018533) (undifferentiated carcinoma of liver and intrahepatic biliary tract), [MONDO:0007256](http://purl.obolibrary.org/obo/MONDO_0007256) (hepatocellular carcinoma), [MONDO:0018055](http://purl.obolibrary.org/obo/MONDO_0018055) (pediatric hepatocellular carcinoma), [MONDO:0014281](http://purl.obolibrary.org/obo/MONDO_0014281) (cholangiocarcinoma, susceptibility to), [MONDO:0019087](http://purl.obolibrary.org/obo/MONDO_0019087) (cholangiocarcinoma), 

**Corr. equiv. classes:** [Orphanet:88673](http://www.orpha.net/ORDO/Orphanet_88673), [Orphanet:424970](http://www.orpha.net/ORDO/Orphanet_424970), [Orphanet:424982](http://www.orpha.net/ORDO/Orphanet_424982), [Orphanet:70567](http://www.orpha.net/ORDO/Orphanet_70567), [Orphanet:424975](http://www.orpha.net/ORDO/Orphanet_424975), [Orphanet:401920](http://www.orpha.net/ORDO/Orphanet_401920), [Orphanet:424943](http://www.orpha.net/ORDO/Orphanet_424943), [Orphanet:33402](http://www.orpha.net/ORDO/Orphanet_33402), [Orphanet:449](http://www.orpha.net/ORDO/Orphanet_449), [OMIM:114550](http://purl.obolibrary.org/obo/OMIM_114550), [OMIM:615619](http://purl.obolibrary.org/obo/OMIM_615619), [Orphanet:210159](http://www.orpha.net/ORDO/Orphanet_210159), 

**Class expressions from DL-Learner:**

- [HP:0002012](http://purl.obolibrary.org/obo/HP_0002012) (Abnormality of the abdominal organs) 24.20%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 22.95%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 21.97%
- Thing 21.97%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 21.97%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 19.89%
- [HP:0007378](http://purl.obolibrary.org/obo/HP_0007378) (Neoplasm of the gastrointestinal tract) 19.57%
- [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) 19.46%
- [HP:0002027](http://purl.obolibrary.org/obo/HP_0002027) (Abdominal pain) 18.43%
- [HP:0012378](http://purl.obolibrary.org/obo/HP_0012378) (Fatigue) 18.31%
- [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) 16.10%
- [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) 15.69%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 15.43%
- [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 14.69%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 14.17%


